StoxLinde India vs UPL: share price & financials comparison
NSE: LINDEINDIA vs UPL · Chemicals · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Linde India vs UPL at a glance
Linde India (LINDEINDIA) has a market capitalisation of ₹58,424 Cr, against ₹47,269 Cr for UPL (UPL). Over the past year Linde India has returned +14.4%, compared with -23.5% for UPL. On valuation, UPL trades at a lower P/E of 25.0 versus 754.3. UPL earns a higher return on equity (5.4% vs 1.8%). Linde India comes out ahead on financial health, momentum and technicals. UPL comes out ahead on size, valuation and profitability. Across the scored metrics below, Linde India leads on 10 and UPL on 7. On StoxGud's 10-point checklist, Linde India scores 5/10 and UPL scores 4/10.
| Metric | Linde India | UPL |
|---|---|---|
| Size | ||
| Market cap | ₹58,424 Cr | ₹47,269 Cr |
| Revenue (latest FY) | ₹2,531 Cr | ₹51,839 Cr |
| Net profit (latest FY) | ₹549 Cr | ₹1,922 Cr |
| Valuation | ||
| P/E | 754.3 | 25.0 |
| P/B | 13.31 | 1.36 |
| Dividend yield | 0.17% | 1.03% |
| Profitability | ||
| Return on equity | 1.8% | 5.4% |
| Net profit margin | 2.8% | 3.6% |
| Operating margin | 31.5% | 18.1% |
| Growth | ||
| Revenue growth (YoY) | +12.3% | -1.3% |
| Net profit growth (YoY) | — | -23.9% |
| Revenue CAGR (multi-year) | +5.3% | +6.4% |
| Financial health | ||
| Debt to equity | 0.22 | 0.94 |
| Momentum | ||
| 1-month return | +14.0% | +6.6% |
| 1-year return | +14.4% | -23.5% |
| 3-year CAGR | +4.2% | +0.4% |
| 5-year CAGR | +22.3% | -6.5% |
| 10-year CAGR | +34.9% | +3.4% |
| Distance from 52W high | -12.7% | -30.5% |
| Technicals | ||
| RSI (14) | 82 | 69 |
| Price vs 200-day avg | +1.7% | -8.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Linde India | UPL |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✗ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✓ |
| Positive 1-year return | ✓ | ✗ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✗ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✓ |
| Score | 5/10 | 4/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Linde India or UPL?
Linde India has a market cap of ₹58,424 Cr and UPL has a market cap of ₹47,269 Cr as of 13 Nov 2026.
Which has a lower P/E, Linde India or UPL?
UPL has the lower P/E: Linde India trades at 754.3 and UPL at 25.0.
Which gave better returns in the last year, Linde India or UPL?
Linde India did better: Linde India returned +14.4% and UPL returned -23.5% over one year.
What is the difference between Linde India and UPL?
Both are NSE-listed companies in Chemicals. Linde India is about 1.2 times the size of UPL by market cap. In the latest financial year Linde India reported revenue of ₹2,531 Cr and UPL ₹51,839 Cr. Operating margin is 31.5% for Linde India and 18.1% for UPL. Debt to equity is 0.22 for Linde India and 0.94 for UPL.
Which is better, Linde India or UPL?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Linde India leads on 10 and UPL on 7. Linde India is ahead on financial health, momentum and technicals. UPL is ahead on size, valuation and profitability. On StoxGud's rules-based checklist Linde India scores 5/10 and UPL scores 4/10. This is information, not advice: consult a SEBI-registered adviser before investing.